GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sareum Holdings PLC (STU:RYH0) » Definitions » Policy Acquisition Expense

Sareum Holdings (STU:RYH0) Policy Acquisition Expense


View and export this data going back to 2021. Start your Free Trial

What is Sareum Holdings Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Sareum Holdings (STU:RYH0) Business Description

Traded in Other Exchanges
Address
Langford Arch, London Road, Unit 2a, Pampisford, Cambridge, Cambridgeshire, GBR, CB22 3FX
Sareum Holdings PLC is engaged in drug discovery and development. The company is focused on cancer and autoimmune diseases and licensing them to pharmaceutical and biotechnology companies. The company's drug pipeline includes SDC-1801 for autoimmune diseases, SDC-1802 for cancers, SRA737 targeting solid tumors among others.